Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of LY3209590 in Participants With Type 1 Diabetes

ClinicalTrials.gov ID: NCT04450407

Public ClinicalTrials.gov record NCT04450407. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 10:13 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The reason for this study is to see if the study drug LY3209590 is safe and effective in participants with type 1 diabetes.

Study identification

NCT ID
NCT04450407
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
266 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 6, 2020 (Actual)
Primary completion
Oct 1, 2021 (Actual)
Completion
Oct 1, 2021 (Actual)
Last update posted
Oct 27, 2022

2020 – 2021

United States locations

U.S. sites
33
U.S. states
16
U.S. cities
32
Facility City State ZIP Site status
John Muir Physician Network Clinical Research Center Concord California 94520 —
Valley Endocrine, Fresno Fresno California 93720 —
Coastal Metabolic Research Centre Ventura California 93003 —
Barbara Davis Center for Childhood Diabetes Aurora Colorado 80045 —
Denver Endocrinology, Diabetes & Thyroid Center Englewood Colorado 80113 —
East Coast Institute for Research at The Jones Center Jacksonville Florida 32204 —
Sun Coast Clinical Research, Inc New Port Richey Florida 34652 —
Bayside Clinical Research, LLC New Port Richey Florida 34655 —
Metabolic Research Institute, Inc. West Palm Beach Florida 33401 —
Atlanta Diabetes Associates Atlanta Georgia 30318 —
East Coast Institute for Research at The Jones Center Macon Georgia 31210 —
Endocrine Research Solutions, Inc. Roswell Georgia 30076 —
Rocky Mountain Clinical Research Idaho Falls Idaho 83404 —
Iowa Diabetes and Endocrinology Research Center West Des Moines Iowa 50265 —
Diabetes and Metabolism Associates, APMC Metairie Louisiana 70006 —
Endocrine and Metabolic Consultants Rockville Maryland 20852 —
Palm Research Center Tenaya Las Vegas Nevada 89128 —
Southern Nh Diabetes and Endocrinology Nashua New Hampshire 03060 —
Suny Health Science Center at Syracuse Syracuse New York 13210 —
Lucas Research, Inc. Morehead City North Carolina 28557 —
PMG Research of Piedmont Healthcare Statesville North Carolina 28625 —
PMG Research of Wilmington Wilmington North Carolina 28401 —
Intend Research, LLC Norman Oklahoma 73069 —
Holston Medical Group Bristol Tennessee 37620 —
Univ Diab & Endo Consult Chattanooga Tennessee 37411 —
Texas Diabetes & Endocrinology, P.A. Austin Texas 78731-4309 —
Research Institute of Dallas Dallas Texas 75231 —
Diabetes and Thyroid Center of Fort Worth Fort Worth Texas 76132 —
Endocrine and Psychiatry Center Houston Texas 77095 —
Southern Endocrinology Associates Mesquite Texas 75149 —
Texas Diabetes & Endocrinology, P.A. Round Rock Texas 78681 —
Consano Clinical Research, LLC Shavano Park Texas 78231 —
Rainier Clinical Research Center Renton Washington 98057 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04450407, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 27, 2022 · Synced Nov 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04450407 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →